Barcelona, Spain

Mireia Pasto

This inventor holds 1 USPTO granted patent. Top assignee: Ferrer Internacional, S.a.. Active years: 2007.


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mireia Pasto: Innovator in Pharmaceutical Chemistry

Introduction

Mireia Pasto is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative processes in drug development. Her work exemplifies the intersection of science and technology, leading to advancements that can impact healthcare.

Latest Patents

Mireia holds a patent for a process titled "Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one." This process involves the condensation of (2-methyl-6,7,8,9-tetrahydro-4 H-pyrido-[1,2-a]pyrimidin-3-yl)-acetaldehyde with 6-fluoro-3-piperidinyl)-1,2-benzisoxazole to yield an intermediate enamine. The subsequent reduction of this enamine leads to the final compound, showcasing her expertise in synthetic organic chemistry.

Career Highlights

Mireia is currently employed at Ferrer Internacional, S.A., where she continues to push the boundaries of pharmaceutical research. Her dedication to innovation has not only resulted in her patent but has also contributed to the development of new therapeutic solutions.

Collaborations

Throughout her career, Mireia has collaborated with esteemed colleagues such as Rafael Foguet and Jorge Ramentol. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Mireia Pasto stands out as a pioneering inventor in the pharmaceutical industry. Her contributions through her patent and collaborative efforts reflect her commitment to advancing healthcare solutions. Her work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…